Fig. 1From: Neoadjuvant irinotecan, cisplatin, and concurrent radiation therapy with celecoxib for patients with locally advanced esophageal cancerKaplan-Meier estimates of overall survival (a) and progression free survival (b) for all 40 patients enrolled in the trialBack to article page